Atlas Trials

A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia

Clinical trial NCT02507102 · COMPLETED

Trial details

NCT number
NCT02507102
Sponsor
Nativis, Inc.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Glioblastoma Multiforme
Start date
2015-08-01
Primary completion
2017-12-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.